THE LATEST NEWS IN CANCER CLINICAL RESEARCH

AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!

DOWNLOAD COMPANY DOSSIER

MEDSIR Study Finds No Progression-Free Survival Benefit with Palbociclib Maintenance After First-Lin

Jun 6, 20233 min read

ANNOUNCEMENTS

MEDSIR Study Finds No Progression-Free Survival Benefit with Palbociclib Maintenance After First-Lin

160 views

Spotlight: BioPER trial for HR+/HER- advanced breast cancer

Mar 30, 20232 min read

CANCER RESEARCH

Spotlight: BioPER trial for HR+/HER- advanced breast cancer

120 views

Spotlight - DxCARTES Early Breast Cancer Trial

Dec 28, 20222 min read

CANCER RESEARCH

Spotlight - DxCARTES Early Breast Cancer Trial

99 views

Safety Analysis of PARSIFAL Trial Published in The Oncologist Journal

Oct 31, 20222 min read

CANCER RESEARCH

Safety Analysis of PARSIFAL Trial Published in The Oncologist Journal

141 views

PARSIFAL: Identifying an endocrine agent for palbociclib in endocrine sensitive ABC

Oct 7, 20212 min read

ANNOUNCEMENTS

PARSIFAL: Identifying an endocrine agent for palbociclib in endocrine sensitive ABC

801 views

Oct 6, 20211 min read

PRESS RELEASE

PARSIFAL Study (breast)

140 views